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LETTERS TO THE EDITORRegarding “Tips and tricks for avoiding access
problems when using large sheath endografts”
We read with interest the timely review by Peterson and
Matsumura.1 Hostile iliofemoral access is a leading constraint to
the general ability of achieving endovascular repair of thoracic and
aortic aneurysms. We would like to draw attention to another
strategy for overcoming this common clinical dilemma that was
not discussed by the authors: utilization of the common carotid
artery. Our institution2 is among other institutions that have
described use of the common carotid artery for thoracic aortic
aneurysm endovascular repair and coverage of penetrating thoracic
aorta ulcers.3-5 More recently, we have used this access route for
abdominal aortic aneurysm repair using a custom made, reverse-
mounted endograft.6
To accommodate a 28F thoracic endograft, the common
carotid artery should be 8 mm in luminal diameter and free of
disease. Accordingly, carotid ultrasound assessment is essential to
measure vessel diameter and atherosclerotic burden. This assess-
ment may be augmented by computed tomography imaging of the
intracranial and extracranial carotid system to visualize vessel cali-
ber and the anastomoses at the circle of Willis. Although carotid
shunting to preserve cerebral perfusion is not possible with this
approach, intraoperative transcranial Doppler measurement of the
middle cerebral artery provides an indication of the patient’s tol-
erance to carotid manipulation.
A further procedural modification to avoid brain hypoxia is
construction of a temporary extracorporeal axillocarotid graft to
maintain cerebral perfusion in the presence of coexisting carotid
disease or retrograde vertebral artery flow.7 A technical hazard to
note from this procedure is “cheese-wiring” of the guidewire
through the aortic wall at the angle of carotid intersection with the
aortic arch. This may been avoided by ensuring that a long sheath
is situated within aorta at all times.
We believe that in appropriately selected patients, the com-
mon carotid arteries provide a practical alternative route for endo-
vascular access for both thoracic and abdominal aortic endovascu-
lar interventions.
Jonathan Ghosh, MD, MA, FRCS
Ferdinand Serracino-Inglott, MD, MSc, FRCS
Manchester Royal Infirmary
Manchester, United Kingdom
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Regarding “Angioplasty with stent graft versus bare
stent for recurrent cephalic arch stenosis in
autogenous arteriovenous access for hemodialysis: A
prospective randomized clinical trial”
David Shemesh et al1 reported significantly better primary
patency rates for covered stents compared to bare stents in early
recurring stenoses of the final arch of the cephalic vein. Although
the authors acknowledge in the Discussion that these “stents can
cause occlusion of the axillary/subclavian vein” so “that the arm is
no longer available for (a new) arteriovenous access construction”,
we disagree when they say that this is a rare phenomenon. From
our previous experience with stents in this location, even stents not
clearly protruding into the axillary/subclavian vein can cause ste-
nosis or occlusion, which then precludes any further creation of a
new ipsilateral vascular access. There are, to date, no criteria to help
predict this severe complication. We have previously emphasized
the drawbacks of axillary-subclavian stents in a published letter.2
We believe that the conclusion of Dr Shemesh’s article pro-
moting placement of covered stents in cephalic arches should be
toned down, since such stent placements should be prohibited in
patients with a reasonably long life expectancy. The preservation of
venous capital in such patients is more important than any slight
prolongation of patency of the brachial-cephalic fistula, which
eventually requires redilation despite covered stent placement.
Unfortunately, it is difficult to predict the likely survival of the
majority of dialysis patients and, thus, the need for precaution
should lead to questioning the majority of potential indications for
stent placement in cephalic arches.
Luc A.E. Turmel-Rodrigues
Clinique Saint-Gatien
Department of Radiology
Tours, France
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Reply
We thank Dr Turmel-Rodrigues for his comment that high-
lights important issues concerning stent insertion for arteriovenous
access in general, extending beyond the specific area of the cephalic
arch discussed in our article.1
Dr Turmel-Rodrigues suggests that stent placement in the
cephalic arch should be avoided. To support this recommendation,
